trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

LSD and tryptamines are neurotoxic rather than harmless

the verdict
REFUTED
the evidence says no
Recorded sources
0 sources for · 6 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that LSD and tryptamines are neurotoxic rather than harmless?

No. Current scientific literature refutes the claim that LSD and tryptamines are neurotoxic, instead highlighting their low physiological toxicity and promising therapeutic applications.

Verdict: REFUTED · 0 sources for, 6 against · Last checked

The analysis

The claim asserts that LSD and tryptamines are neurotoxic rather than harmless. The retrieved papers consistently characterize classic psychedelics and tryptamines (such as LSD, DMT, and psilocin/psilocybin) as compounds with low physiological toxicity, good safety profiles, and promising neuroplastic and therapeutic properties for psychiatric conditions, rather than neurotoxic agents. Therefore, the evidence firmly refutes the claim.

Evidence against · 6
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
2022
Notes that classic psychedelics including LSD are evaluated as having low physiological toxicity and no persisting adverse physiological effects.
Get citation
H, L., N, T., B, S., J, G., A, A., L, G., & W, N. (2022). Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.. doi.org. https://doi.org/10.3390/molecules27082520

See more details
More against · 5
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.
2024
Discusses LSD, DMT, and other psychedelics as potential therapeutic agents with established safety profiles rather than neurotoxic hazards.
Get citation
TG, Z., KM, J., R, B., JH, A., PA, B., C, M., C, P., H, C., MT, M., C, S., G, D., L, L., & R, Y. (2024). The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.. doi.org. https://doi.org/10.2174/1570159x22666231027111147

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.
2024
Highlights the neuroplastic and therapeutic potential of DMT without indicating neurotoxicity.
Get citation
K, E., HD, A., P, C., & M, S. (2024). Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.. doi.org. https://doi.org/10.1007/s00018-024-05353-6

Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.
2025
Examines the diverse pharmacological effects of LSD and psilocybin as promising treatments for mental disorders, contradicting claims of intrinsic neurotoxicity.
Get citation
SH, K., S, Y., J, J., J, C., M, K., & JY, J. (2025). Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.. doi.org. https://doi.org/10.1002/advs.202413786

Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.
2025
Reviews psilocybin and psilocin as fast-acting antidepressants with favorable neuroplastic properties rather than neurotoxic mechanisms.
Get citation
M, A., M, B., O, L., C, D., JC, M., F, B., DJ, D., E, P., L, T., & AM, G. (2025). Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.. doi.org. https://doi.org/10.1111/fcp.70038

The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior.
2026
Demonstrates that psilocin (a tryptamine) engages neural circuitry in a regulated, receptor-balanced manner with distinct therapeutic potential.
Get citation
Z, K., I, S., A, B., & K, G. (2026). The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior.. doi.org. https://doi.org/10.1007/s43440-025-00817-3

What does the evidence say?

The claim asserts that LSD and tryptamines are neurotoxic rather than harmless. The retrieved papers consistently characterize classic psychedelics and tryptamines (such as LSD, DMT, and psilocin/psilocybin) as compounds with low physiological toxicity, good safety profiles, and promising neuroplastic and therapeutic properties for psychiatric conditions, rather than neurotoxic agents. Therefore, the evidence firmly refutes the claim.

Receipt History
first checked04 Aug 2026
judged → REFUTED · 1004 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work